•
Jun 30, 2012

Cocrystal Pharma Q2 2012 Earnings Report

Total Revenue
$4.91M
Previous year: $2.57M
+91.1%
EPS
-$0.01
Previous year: -$0.03
-66.7%
Gross Profit
$2.03M
Previous year: $1.26M
+60.8%
Cash and Equivalents
$174K
Previous year: $1.84M
-90.5%
Total Assets
$9.07M
Previous year: $11.1M
-18.4%

Cocrystal Pharma

Cocrystal Pharma